glp 1 bone density loss GLP-1 Use Associated with Lower Osteoporosis Risk in Adults with Type 2 Diabetes but Higher Risk in Adults Without Diabetes GLP-1s and bone loss!

Learn how alcohol may affect GLP-1 medications, potential side effects, and practical tips for drinking more safely.

Novo Nordisk and Ascendis Pharma have partnered to develop a long-acting, monthly GLP-1 drug

The Food and Drug Administration (FDA) on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and Wegovy, is no longer in short supply. | The demand for weight loss drugs is not slowing down, and many organizations voiced concerns there will likely be semaglutide shortages in the future that will impact patients' access to weight loss medications.

That's the right next step

As we approach this transition, we know you may have many questions about availability, substitutions, cost, insurance coverage, and more

A National Institutes of Health (NIH)-funded study has found that an emerging class of GLP-1 weight loss drugs suppress eating for pleasure, or hedonic feeding, in mice by modulating a reward circuit deep within the brain